Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar-Apr;31(2):304-8.
doi: 10.12669/pjms.312.6462.

Malabsorption of iron as a cause of iron deficiency anemia in postmenopausal women

Khansa Qamar  1 , Muhammad Saboor  2 , Fatima Qudsia  3 , Shafi Muhammad Khosa  4 , Moinuddin  5 , Muhammad Usman  6
Affiliations

Malabsorption of iron as a cause of iron deficiency anemia in postmenopausal women

Khansa Qamar et al. Pak J Med Sci. 2015 Mar-Apr.

Abstract

Objective: Malabsorption is one of the causes of iron deficiency anemia in postmenopausal women. The main objective of this study was to access the frequency of malabsorption in iron deficient anemic postmenopausal women.

Methods: A total of 123 postmenopausal women were enrolled in the study. Of these 123 women, 50 were included as 'control group' and 73 patients with comparable severity of anemia were the 'patient group'. Two tablets of ferrous sulfate (200 mg/tablet) along with one tablet of vitamin C (500 mg) were given to all participants. Serum iron levels were determined on samples collected from all participants before and after the administration of ferrous sulfate. Difference between before and after serum iron levels of normal and patients were compared.

Results: No change in serum iron between sample one and sample two represented malabsorption. Out of 73, 5 postmenopausal anemic patients showed no change in their serum iron level after the administration of ferrous sulfate. This study shows that frequency of malabsorption of iron in postmenopausal women is 6.8%.

Conclusion: Malabsorption should be considered as a prevalent cause of iron deficiency anemia in postmenopausal women. It should be properly diagnosed and iron response should be monitored properly in postmenopausal women with IDA after oral iron therapy. If a postmenopausal woman does not show any response to oral iron therapy, she should be evaluated for iron loss (blood loss and/or malabsorption). Intravenous route should be used for the administration of iron in these patients.

Keywords: Iron deficiency anemia; Malabsorption; Postmenopausal women.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nils M. Anemia—still a major health problem in many parts of the world. Ann Hematol. 2011;90(4):369–377. doi:10.1007/s00277-010-1144-5. - PubMed
    1. Clark SF. Iron deficiency anemia: diagnosis and management. Curr Opin Gastroenterol. 2009;25(2):122–128. doi:10.1097/MOG.0b013e32831ef1cd. - PubMed
    1. Jeffery LM. Iron deficiency anemia: a common and curable disease. Cold Spring Harb Perspect Med. 2013;3(7):a011866. doi:10.1101/cshperspect.a011866. - PMC - PubMed
    1. Gnana-Prakasam JP, Martin PM, Smith SB, Ganapathy V. Expression and function of iron-regulatory proteins in retina. IUBMB Life. 2010;62(5):363–370. doi:10.1002/iub.326. - PMC - PubMed
    1. Iqbal MS, Ahmed MS, Ogras TT, Ullah S, Asif JH, Keshavarzi F. Diagnosis & management of iron deficiency anemia via parental Iron. Int J Nat Sci. 2012;2(3):88–90. doi:10.3329/ijns.v2i3.12138.